Catalog No.
YVV44004
Expression system
E. coli
Species
AKV murine leukemia virus (AKR (endogenous) murine leukemia virus)
Protein length
Ala478-Asp537
Predicted molecular weight
8.82 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P03336
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Gag polyprotein, Capsid protein, gag, Core polyprotein, Nucleocapsid protein p10-gag, NC-gag
A Novel Thermostable and Processive Reverse Transcriptase from a Group II Intron of Anoxybacillus flavithermus., PMID:38254649
Polypyridyl ruthenium complexes as bifunctional TAR RNA binders and HIV-1 reverse transcriptase inhibitors., PMID:35679745
RNA Structural Requirements for Nucleocapsid Protein-Mediated Extended Dimer Formation., PMID:35337013
Physiological magnesium concentrations increase fidelity of diverse reverse transcriptases from HIV-1, HIV-2, and foamy virus, but not MuLV or AMV., PMID:34904939
The attachment of a DNA-binding Sso7d-like protein improves processivity and resistance to inhibitors of M-MuLV reverse transcriptase., PMID:32970841
Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing., PMID:31830125
Decreased Km to dNTPs is an essential M-MuLV reverse transcriptase adoption required to perform efficient cDNA synthesis in One-Step RT-PCR assay., PMID:29608777
Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors., PMID:28449719
Synthesis of Pyridone-based Nucleoside Analogues as Substrates or Inhibitors of DNA Polymerases., PMID:26854871
Selective binding and reverse transcription inhibition of single-strand poly(A) RNA by metal TMPyP complexes., PMID:25203754
Gammaretrovirus mRNA expression is mediated by a novel, bipartite post-transcriptional regulatory element., PMID:25190459
Modulation of stop codon read-through efficiency and its effect on the replication of murine leukemia virus., PMID:24991001
Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro., PMID:24850729
Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein., PMID:23810854
Compartmentalization of destabilized enzyme-mRNA-ribosome complexes generated by ribosome display: a novel tool for the directed evolution of enzymes., PMID:23667164
Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag., PMID:23661057
MoMuLV and HIV-1 nucleocapsid proteins have a common role in genomic RNA packaging but different in late reverse transcription., PMID:23236513
Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract., PMID:22848574
Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms., PMID:22828015
Generation and characterization of new highly thermostable and processive M-MuLV reverse transcriptase variants., PMID:22691702
Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties., PMID:22076653
Selective inactivation of M-MuLV RT RNase H activity by site-directed PEGylation: an improved ability to synthesize long cDNA molecules., PMID:21807127
The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag., PMID:21343359
Fluoride-cleavable, fluorescently labelled reversible terminators: synthesis and use in primer extension., PMID:21294195
The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3., PMID:20702647
Mass spectrometry of murine leukemia virus core proteins., PMID:20691207
Biochemical characterization of enzyme fidelity of influenza A virus RNA polymerase complex., PMID:20454455
Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H., PMID:20122939
Inactivation of respiratory syncytial virus by zinc finger reactive compounds., PMID:20102602
Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts., PMID:20080538
Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix., PMID:19828619
Influence of the RNase H domain of retroviral reverse transcriptases on the metal specificity and substrate selection of their polymerase domains., PMID:19814799
Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells., PMID:19549607
Physiological properties of astroglial cell lines derived from mice with high (SAMP8) and low (SAMR1, ICR) levels of endogenous retrovirus., PMID:19032740
Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula., PMID:18842718
Deoxynucleoside triphosphate incorporation mechanism of foamy virus (FV) reverse transcriptase: implications for cell tropism of FV., PMID:18508890
Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate., PMID:18209202
Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge., PMID:17707956
Viral insertion in Evi12 causes expression of aberrant Grp94 mRNAs containing the viral gag myristylation motif., PMID:17543366
Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo., PMID:17532359
tRNA isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral translation., PMID:17301132
Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release., PMID:17267509
Consideration of the three-dimensional structure of core shells (capsids) in spherical retroviruses., PMID:17223564
Molecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313)., PMID:17147829
Characterization of a nucleocapsid-like region and of two distinct primer tRNALys,2 binding sites in the endogenous retrovirus Gypsy., PMID:17040893
Retrovirus infection strongly enhances scrapie infectivity release in cell culture., PMID:16724107
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH., PMID:16359234
A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance., PMID:15843538
Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases., PMID:15823610
Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue., PMID:15701045
For research use only. Not for human or drug use.
